3[5]Ling ZC,Khan A,Delauny F,et al.Increased glucocorticoid sensitivity in islet beta-cells:effects on glucose 6-phosphase,glucose cycling and insulin release.Diabetologia.1998,41 (6):634-639.
4Godwin M,Dawes M.Intra-articular steroid injections for painful knees.Systematic review with meta-analysis[J].Can-Fam-Physician,2004,50:241-248.
5Tegner Y,Lysholm J.Rating systems in the evaluation of knee ligament injuries[J].Clin Orthop,1985,198:43-49.
6Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum, 2000, 43: 1905-1915.
7Schnitzer TJ, American College of Rheumatology. Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage, 2002, 23(4 Suppl): S24-34.
8Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅱ. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum, 1995, 38:1541-1546.
9Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅰ. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum, 1995, 38: 1535-1540.
10Simon LS, Lipman AG, Jacox AK, eds. Pain in osteoarthritis, rheumatoid arthritis and juvenile chronic arthritis. 2nd ed. Glenview (IL): American Pain Society (APS), 2002. 179.
4Onyenwenyi AJ,Winterstein AG,Hatton RC.An evaluation of the effects of gatifloxacin on glucose homeostasis[J].Pharm World Sci,2008,30(5):544.
5Chou HW,Wang JL,Chang CH,et al.Risk of severe dysglycemia among diabetic patients receiving levofloxacin,ciprofloxacin,or moxifloxacin in Taiwan[J].Clin Infect Dis,2013,57(7):971.
6Smith SM,Anderson SD,Wen S,et al.Lack of correlation between thiazide-induced hyperglycemia and hypokalemia:subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses(PEAR)study[J].Pharmacotherapy,2009,29(10):1 157.
7Gress TW,Nieto FJ,Shahar E,et al.Hypertension and anti-hypertensive therapy as risk factors for type 2 diabetes mellitus.Atherosclerosis Risk in Communities Study[J].N Engl J Med,2000,342(13):905.
8Lindholm LH,Carlberg B,Samuelsson O.Should beta blockers remain first choice in the treatment of primary hypertension?A meta-analysis[J].Lancet,2005(9 496):1 545.
9Fonarow GC,Deedwania P,Fonseca V,et al.Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension:results of the extended-release carvedilol lipid trial[J].J Am Soc Hypertens,2009,3(3):210.
10Scheen AJ.Renin angiotensin system inhibition prevents type 2 diabetes mellitus.Part1.Meta analysis of randomized clinical trials[J].Diabetes Metab,2004,30(6):487.
